Reynolds American launches U.S. investment plan: to invest $3.2 billion to expand capacity and advance a shift toward smokeless products

Mar.06
Reynolds American launches U.S. investment plan: to invest $3.2 billion to expand capacity and advance a shift toward smokeless products
Reynolds American says it will invest more than $3.2 billion across its U.S. operations by 2030. The investment began in 2024 and is expected to support more than 2,000 direct and indirect jobs. The company says the plan covers modernization and expansion of manufacturing facilities, scaling innovation and production, supply-chain initiatives and employee training, and also references its R&D spending and related site footprint.

Key Takeaways

 

  • Reynolds American announced it will invest more than $3.2 billion in its U.S. operations by 2030;
  • The investment began in 2024 and is expected to support more than 2,000 direct and indirect jobs;
  • The company says it has invested more than $200 million in U.S. manufacturing over the past two years;
  • The company says its sites in Winston-Salem, North Carolina, and Clarksville, Tennessee, will continue to be modernized and expanded;
  • The company says it employs hundreds of scientists in Winston-Salem and invests about $100 million annually in R&D, mainly for smokeless-category development.

 


2Firsts, March 6, 2026

 

According to PRNewswire, Reynolds American announced a plan to invest more than $3.2 billion across its U.S. operations by 2030. The company says the investment began in 2024 and is expected to support more than 2,000 direct and indirect jobs across Reynolds American’s operations and U.S. supply network, including roles tied to manufacturing expansion and innovation initiatives.

 

The company says the announcement also launched the “Growing Tomorrow” program. The company says the program is tied to its business advancement and involves its multi-category nicotine product business.

 

David Waterfield, President and CEO of Reynolds American, referenced the program in the plan, saying it relates to the company’s investments in U.S. manufacturing and jobs, and also mentioned expanding manufacturing capabilities and strengthening the workforce.

 

In the “Growing Performance” section, the company says the investment will support its transition toward “a predominantly smokeless future” and focus on high-growth categories. The company lists multi-year investment priorities including modernization and expansion of U.S. manufacturing, scaling innovation and production, strengthening domestic supply chains, and advancing workforce capabilities and operational improvement. The company also says that, as part of this commitment, more than $200 million has already been invested in U.S. manufacturing over the past two years.

 

In the “Growing Innovation” section, the company says its research and manufacturing hub in Winston-Salem, North Carolina, and its operations site in Clarksville, Tennessee, will support related R&D and production arrangements. The company says planned investments will modernize facilities and expand production capacity. The company also says it employs hundreds of scientists in Winston-Salem and is supported by approximately $100 million in annual R&D investment, most of which is focused on smokeless-category development.

 

In the “Growing Careers & Community” section, the company says it employs more than 4,300 people across the U.S., with roles spanning advanced manufacturing, engineering, science, skilled operations and corporate functions. The company says it will continue investing in technology, training and workforce readiness, and that it will generate related impacts through its supply network. Borgia Walker, Senior Vice President and Chief People Officer at Reynolds American, said in the plan that the company will focus on capability building, expanding opportunities and employee career development.

 

The company also notes links between its business and agriculture and local economies, and says North Carolina is a major U.S. tobacco-producing state, with farmers and agricultural partners connected to its domestic supply chain. The company says that in 2025 it was the largest purchaser of U.S. tobacco leaf produced by American farmers.

 

The company says “Growing Tomorrow” is linked to its investment plan through 2030 and will cover manufacturing, R&D and workforce-related arrangements across its U.S. operations.

 

Image Source: PRNewswire

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

 PMI Opens Generative AI Center in Portugal to Support Global Operations
PMI Opens Generative AI Center in Portugal to Support Global Operations
According to information released by Portugal’s Trade & Investment Agency (AICEP) in July 2026, Philip Morris International (PMI) has established a global Generative Artificial Intelligence Factory (GenAI Factory) at its Portuguese subsidiary Tabaqueira. The center will support PMI’s global operations by developing and deploying AI solutions focused on industrial process optimization, data analytics, operational automation and AI application development. The initiative strengthens Portugal’s role in PMI’s global technology and innovation network.
Aug.27
China’s Zhengzhou Tobacco Research Institute develops end-to-end heated tobacco analysis to trace aerosol compound origins
China’s Zhengzhou Tobacco Research Institute develops end-to-end heated tobacco analysis to trace aerosol compound origins
The Zhengzhou Tobacco Research Institute of China National Tobacco Corporation has filed a patent application for an end-to-end method to analyze the migration and transformation of chemical compounds in heated tobacco products. Using GC-Orbitrap/MS non-targeted analysis, the method compares tobacco substrate and aerosol samples to distinguish compounds transferred directly from the substrate from those newly formed during heating, while also calculating transfer rates. In an example involving nine heated tobacco products, the patent identified 17 newly formed thermal decomposition compounds and 38 transferred compounds.
Aug.13
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
The U.S. Food and Drug Administration authorized 11 ZYN ULTRA nicotine pouch products made by Swedish Match USA through the premarket tobacco product application pathway on August 21, 2026. Ten of the authorized products have a labeled nicotine content of 9 mg, while ZYN ULTRA Smooth was authorized at 11 mg. The reviews were conducted through FDA’s nicotine pouch PMTA pilot program. FDA has now authorized 43 nicotine pouch products, including 23 through the pilot.
Aug.24
French Anti-Tobacco Group Questions PMI’s IQOS “Curiosity” Campaign Over Potential Youth Appeal
French Anti-Tobacco Group Questions PMI’s IQOS “Curiosity” Campaign Over Potential Youth Appeal
According to French anti-tobacco group Générations Sans Tabac, Philip Morris International’s (PMI) IQOS “Curiosity” campaign has drawn attention from public health advocates. The group argues that the campaign uses themes including curiosity, exploration and lifestyle branding that could increase interest among younger audiences. PMI has positioned IQOS as a key part of its smoke-free product strategy, while France maintains strict restrictions on tobacco and nicotine product marketing. The debate highlights ongoing tensions between heated tobacco branding strategies and public health concerns in Europe.
Jul.24
New York’s 75% Wholesale Tax on Nicotine Pouches Takes Effect Sept. 1, With Aug. 31 Inventory Subject to Floor Tax
New York’s 75% Wholesale Tax on Nicotine Pouches Takes Effect Sept. 1, With Aug. 31 Inventory Subject to Floor Tax
New York State will extend its tobacco products tax to “alternative nicotine products,” including tobacco-free nicotine pouches, from September 1, 2026, at a rate of 75% of the wholesale price. Distributors, wholesalers and retailers must also inventory products held as of 11:59 p.m. on August 31 and pay a floor tax. Vapor products are excluded from the new category and remain subject to New York's separate 20% supplemental sales tax on the retail price.
Aug.26
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
A new Swedish study found oral mucosal lesions in 79% of examined nicotine pouch users and 89% of tobacco-derived snus users, with different tissue-response patterns between the two categories. For manufacturers and regulators, the findings shift attention toward product formulation, flavouring, pouch materials and local oral exposure, not only whether a product contains tobacco. The study found no higher prevalence of caries or periodontal disease, but it could not establish causality, long-term outcomes or differences between individual products or designs.
Special Report
Jul.27